A short-term randomized study of active surveillance for prostate cancer showed that fish oil supplementation was associated ...

NHS data on 13 of the most common cancers - such as breast, prostate and lung - shows nearly three in five patients are now ...

Here the authors report the results of a phase 1 trial of PSCA-directed autologous CAR-T cells with pharmacological activation by rimiducid in patients with metastatic pancreatic or prostate cancer.

Each year in the UK about 47,600 people are diagnosed with prostate cancer, but a new study has now revealed that a simple dietary change could hold the key to stopping the early stages of the ...

Prostate cancer may cause pain, difficulty in urinating, problems during sexual intercourse, or erectile dysfunction. Other symptoms can potentially develop during later stages of the disease.

CP-506 is under clinical development by Convert Pharmaceuticals and currently in Phase II for Prostate Cancer.

This is usually to confirm and grade prostate cancer in a patient with an elevated ... detection rate of targeted biopsies, but at this stage cannot be used to replace systematic biopsy.

Prostate cancer, especially in advanced stages such as castration-resistant ... the potential of azolato-bridged dinuclear platinum(II) complexes, particularly 5-H-Y, as promising alternatives.

Stenoparib is under clinical development by Allarity Therapeutics and currently in Phase I for Prostate Cancer.

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming ... development of castrate resistance. [2] However, the advent of several new agents ...